Valeant Pharmaceuticals International Inc


Valeant Pharmaceuticals Intl Inc (VRX) Announces Tender Offer for 6.75% Senior Notes Due 2018

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has commenced an offer to purchase for cash up to $600,000,000 aggregate principal amount of the Company’s outstanding …

Morgan Stanley Highlights Five Big Questions for Valeant Pharmaceuticals Intl Inc (VRX) Ahead of Upcoming Earnings Report

Analyst David Risinger from Morgan Stanley presented five questions he would like to see answered in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) upcoming earnings report …

Why This Analyst Thinks Valeant Pharmaceuticals Intl Inc Is Still Doomed

Analyst David Maris of Wells Fargo weighs in on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) ahead of second-quarter earnings, stating that he doesn’t see any indication that the troubled drug maker …

Company Update (NYSE:VRX): Valeant Pharmaceuticals Intl Inc Appoints Thomas W. Ross, Sr. Lead Independent Director

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) announced that its Board of Directors has appointed Thomas W.

Monday Morning Market Insights: Valeant Pharmaceuticals Intl Inc (VRX), Tribune Publishing Co (TPUB), Anavex Life Sciences Corp (AVXL)

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is up over 5% in pre-market trading after the company announced the appointment of new CEO Joseph Papa, …

Analysts Weigh In on Two Healthcare Giants: Gilead Sciences, Inc. (GILD), Valeant Pharmaceuticals Intl Inc (VRX)

After two consecutive winning days, the major indexes suffered losses on Thursday, with the iShares Nasdaq Biotechnology Index losing 1.14%.

Biotech Beat: Analysts Weigh In on Advaxis, Inc. (ADXS), Valeant Pharmaceuticals International Inc (VRX) and Agenus Inc (AGN)

Considerable strength remains visible among biotechnology stocks, as reflected by the 2.25 percent gain being posted by the iShares NASDAQ Biotechnology Index today.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts